Literature DB >> 3839952

Correct sequence for the major nucleocapsid protein mRNA of respiratory syncytial virus.

P L Collins, K Anderson, S J Langer, G W Wertz.   

Abstract

A nucleotide sequence for the mRNA of the major nucleocapsid (N) protein gene of respiratory syncytial virus was reported previously (N. Elango and S. Venkatesen, 1983, Nucleic Acids Res. 11, 5941-5951). However, we have been unable to confirm part of this sequence as N mRNA-specific and suggest that the published sequence represents that of an aberrant chimeric transcript. Here we present an alternative sequence for the N mRNA and provide data supporting its authenticity. The corrected N mRNA sequence contains 1197 rather than 1427 nucleotides exclusive of poly(A), and encodes a protein of 391 rather than 467 amino acids. The calculated molecular weight for the 391-amino acid protein described by the sequence presented here is 42,600, in agreement with the molecular weight of 42,000 determined for the RS viral N protein by gel electrophoresis. In addition, we present sequence data from dicistronic RNAs that span the junction between the 1B protein and N cistrons, and the junction between the N and phosphoprotein (P) cistrons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839952     DOI: 10.1016/0042-6822(85)90053-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Molecular characterization of an outbreak of respiratory syncytial virus (subgroup A) in Havana, Cuba, by monoclonal antibodies and restriction mapping (N gene).

Authors:  A Valdivia; D Chacón; C Savón; S Oropesa; L Sarmiento; O Valdes; A Otero; D Rosario; A Goyenechea
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Molecular cloning of pneumonia virus of mice.

Authors:  P Chambers; J Barr; C R Pringle; A J Easton
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.

Authors:  J A Nicholas; K L Rubino; M E Levely; E G Adams; P L Collins
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.

Authors:  P L Earl; A W Hügin; B Moss
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

5.  Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice.

Authors:  A M King; E J Stott; S J Langer; K K Young; L A Ball; G W Wertz
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

6.  Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order.

Authors:  P L Collins; L E Dickens; A Buckler-White; R A Olmsted; M K Spriggs; E Camargo; K V Coelingh
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.

Authors:  H Grosfeld; M G Hill; P L Collins
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains.

Authors:  Marietjie Venter; Michael Rock; Adrian J Puren; Caroline T Tiemessen; James E Crowe
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains.

Authors:  Nathalie Bastien; Susan Normand; Tracy Taylor; Diane Ward; Teresa C T Peret; Guy Boivin; Larry J Anderson; Yan Li
Journal:  Virus Res       Date:  2003-05       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.